TransMedics Group Inc. (TMDX)
NASDAQ · Healthcare
TransMedics Group Inc. EBITDA 2018–2025
TransMedics Group Inc. annual/quarterly ebitda history and growth rate from 2018 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- TransMedics Group Inc. ebitda for the quarter ending March 31, 2026 was 25.2 M, a 25.07% decrease year-over-year.
- TransMedics Group Inc. ebitda for the twelve months ending March 31, 2026 was 74.7 M, a 363.94% decrease year-over-year.
- TransMedics Group Inc. annual ebitda for 2025 was 135.8 M, a 137.13% increase from 2024.
- TransMedics Group Inc. annual ebitda for 2024 was 57.3 M, a 378.61% decrease from 2023.
- TransMedics Group Inc. annual ebitda for 2023 was -20.6 M, a 26.50% decrease from 2022.
- TransMedics Group Inc. annual ebitda for 2022 was -28.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TransMedics Group Inc. EBITDA — FAQ
TransMedics Group Inc. (TMDX) ebitda over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMDX's ebitda history?
The chart and table above show TransMedics Group Inc.'s ebitda by year and by quarter, including the growth rate.